Qiang Dong Selected Research

1-naphthol-8-amino-3,6-disulfonic acid

3/2014

Acid-sensing ion channels activation and hypoxia upregulate Homer1a expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiang Dong Research Topics

Disease

68	Ischemic Stroke 03/2024 - 06/2007
68	Stroke (Strokes) 03/2024 - 06/2007
49	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 12/2012
35	Neoplasms (Cancer) 05/2024 - 08/2011
28	Cognitive Dysfunction 12/2023 - 10/2019
27	Dementia (Dementias) 02/2024 - 01/2020
22	Cerebral Hemorrhage 01/2024 - 05/2004
20	Brain Ischemia (Cerebral Ischemia) 01/2021 - 01/2009
16	Infarction (Infarctions) 03/2024 - 06/2007
14	Pathologic Constriction (Stenosis) 01/2024 - 01/2011
13	Hemorrhage 01/2024 - 07/2013
12	Hypertension (High Blood Pressure) 01/2023 - 05/2004
11	Inflammation (Inflammations) 04/2024 - 09/2006
11	Atrophy 01/2023 - 04/2002
11	Hypoxia (Hypoxemia) 10/2019 - 01/2009
10	Disease Progression 11/2023 - 01/2020
10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 06/2011
8	Infections 07/2023 - 09/2006
8	Parkinson Disease (Parkinson's Disease) 03/2023 - 01/2015
8	Ischemia 01/2021 - 06/2009
7	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 06/2015
6	Glioma (Gliomas) 05/2024 - 03/2019
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 09/2015
6	Nervous System Diseases (Neurological Disorders) 01/2023 - 01/2009
6	Hematoma 01/2022 - 05/2004
6	Transient Ischemic Attack 12/2021 - 02/2012
6	Atherosclerosis 12/2021 - 01/2011
5	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 10/2019
5	Multiple Sclerosis 01/2024 - 06/2011
5	Neuroinflammatory Diseases 01/2024 - 01/2016
5	Pain (Aches) 12/2023 - 11/2006
5	Erectile Dysfunction 01/2022 - 07/2014
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2020 - 08/2011
5	Brain Edema (Cerebral Edema) 09/2017 - 06/2010
5	Acidosis 03/2014 - 10/2009
4	Femoral Neck Fractures 05/2024 - 08/2019
4	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2024 - 05/2014
4	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2023 - 04/2002
4	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2021
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2022 - 11/2014
4	Hemorrhagic Stroke 04/2019 - 06/2011
4	Spinal Cord Injuries (Spinal Cord Injury) 03/2014 - 06/2007
3	Pneumonia (Pneumonitis) 12/2023 - 12/2018
3	Anemia 12/2023 - 10/2022
3	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 04/2019
3	Wounds and Injuries (Trauma) 09/2023 - 03/2014
3	Atrial Fibrillation 10/2022 - 11/2015

Drug/Important Bio-Agent (IBA)

51	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2017
29	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2002
20	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2024 - 03/2014
18	Amyloid (Amyloid Fibrils)IBA 03/2023 - 01/2020
17	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 10/2009
10	Neuroprotective AgentsIBA 01/2021 - 01/2009
9	Cytidine Triphosphate (CTP)IBA 01/2023 - 03/2016
9	Tissue Kallikreins (Tissue Kallikrein)IBA 02/2020 - 10/2009
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024 - 06/2007
8	Messenger RNA (mRNA)IBA 01/2022 - 06/2007
8	Clopidogrel (Plavix)FDA Link 01/2022 - 07/2013
7	AntigensIBA 01/2023 - 11/2007
6	CytokinesIBA 05/2024 - 06/2007
6	LipidsIBA 01/2024 - 08/2011
6	Oxygen (Dioxygen)IBA 01/2023 - 10/2009
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2017
5	Glutamic Acid (Glutamate)FDA Link 01/2020 - 12/2009
5	Therapeutic UsesIBA 08/2019 - 06/2007
5	Testosterone (Sustanon)FDA Link 01/2016 - 04/2002
4	Glutamine (L-Glutamine)FDA Link 04/2024 - 08/2011
4	oxidized low density lipoproteinIBA 01/2024 - 01/2016
4	LDL Lipoproteins (beta Lipoproteins)IBA 12/2023 - 06/2007
4	Apolipoproteins E (ApoE)IBA 11/2023 - 04/2014
4	AlbuminsIBA 12/2022 - 12/2015
4	Hormones (Hormone)IBA 10/2022 - 04/2012
4	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2021
4	Uric Acid (Urate)IBA 01/2022 - 01/2017
4	Cytochrome P-450 CYP2C19IBA 12/2021 - 09/2013
4	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2016
4	Histones (Histone)IBA 02/2020 - 06/2011
4	Histone Deacetylase InhibitorsIBA 02/2020 - 06/2011
3	Nonesterified Fatty Acids (NEFA)IBA 03/2024 - 01/2015
3	Diethylhexyl Phthalate (DEHP)IBA 02/2024 - 07/2007
3	phthalic acid (phthalate)IBA 02/2024 - 01/2021
3	AnticoagulantsIBA 12/2023 - 11/2015
3	Circular RNAIBA 10/2023 - 01/2022
3	CurcuminIBA 09/2023 - 01/2018
3	Glial Fibrillary Acidic ProteinIBA 03/2023 - 01/2023
3	C-Reactive ProteinIBA 03/2023 - 11/2012
3	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2015
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023 - 01/2016
3	SugarsIBA 01/2023 - 10/2010
3	MicroRNAs (MicroRNA)IBA 01/2023 - 03/2019

Therapy/Procedure

48	Therapeutics 04/2024 - 06/2007
9	Thrombectomy 03/2024 - 07/2017
8	Length of Stay 12/2023 - 06/2007
6	Secondary Prevention 01/2022 - 02/2012
5	Drug Therapy (Chemotherapy) 10/2022 - 01/2019
4	Stents 11/2023 - 11/2015
4	Prostatectomy (Retropubic Prostatectomy) 04/2022 - 07/2014
4	Radiotherapy 04/2022 - 10/2021
3	Transplantation 05/2024 - 08/2011
3	Immunotherapy 04/2024 - 05/2019